Monsanto Company (MON) Releases Earnings Results, Beats Expectations By $0.10 EPS

Monsanto Company (MON) announced its most recent quarterly financial results on Wednesday, Oct-5-2016. MON said it had a profit of $0.07 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.10. Analysts had a consensus of $-0.03. The company posted revenue of $2562.00 million in the period, compared to analysts expectations of $2379.03 million. MON’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.19 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Monness Crespi & Hardt on Oct 3, 2016 to “Buy” and Lowered the Price Target to $ 128 from a previous price target of $130 .Monsanto Company was Upgraded by Goldman to ” Neutral” on Sep 27, 2016. Monsanto Company was Upgraded by Bernstein to ” Mkt Perform” on Sep 26, 2016.

Monsanto Company closed down -0.32 points or -0.31% at $102.15 with 33,05,007 shares getting traded on Tuesday. Post opening the session at $102.82, the shares hit an intraday low of $102.1 and an intraday high of $102.88 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

In a different news, on Jul 15, 2016, Michael K Stern (VP, CEO – Climate) sold 12,797 shares at $101.77 per share price. According to the SEC, on Jul 15, 2016, Brett D Begemann (President & COO) sold 27,980 shares at $103.62 per share price. On Apr 21, 2016, George Poste (director) sold 1,136 shares at $91.93 per share price, according to the Form-4 filing with the securities and exchange commission.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Monsanto Company

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.